Tuesday 9th February 2021

(3 years, 2 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

I am aware of and also worried about the continued high rates of infections in north Northants, which has not had a particularly bad pandemic thus far but now, at this point, seems to have a stubbornly high infection rate. I am absolutely up for all measures that might help to get it down, including mass testing. I will take that idea away, work on it with colleagues and return to my hon. Friend and his north Northants colleagues with a proposal.

Jonathan Edwards Portrait Jonathan Edwards (Carmarthen East and Dinefwr) (Ind) [V]
- Hansard - -

The pandemic has been particularly difficult for those with a weak immune system; I therefore welcome the fact that UK Research and Innovation has provided funding to support research on vaccine responses in groups of immunosuppressed individuals, such as high-risk cancer patients. When does the Secretary of State expect the Joint Committee on Vaccination and Immunisation to have enough data to develop a vaccine-protective strategy for immunosuppressed individuals that details whether any specific vaccine is preferred for this cohort?

Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

This is a very important consideration. For those for whom the vaccine is clinically inappropriate, clearly the single most important thing is that everybody else gets the vaccine because that is what can best keep them safe. When we say that the vaccine is “good for you and good for others”, that includes those who are clinically unable to take the vaccine to protect themselves, so everybody around them needs to take the vaccine in order to protect them. More broadly, that work is under way. I will ask the deputy chief medical officer to write to the hon. Gentleman to set out the precise clinical details.